---
title: "T-DM1"
slug: "t-dm"
date: "2023-10-09"
enableToc: false
tags:
  - building
---

> [!info]
>
> ðŸŒ± ä¾†è‡ª: [[Stage II-of-Preoperative Chemotherapy for Operable Breast Cancer]]

# T-DM1

- Ado-trastuzumab emtansine (Kadcyla)
- Mechanism: HER2-targeted antibodyâ€“drug conjugated to the antimicrotubular maytansinoid agent, [[mertansine]] (DM1)
- Dosing: 3.6 mg/kg every 3 wks, no renal or hepatic adjustments
- PK/PD: T1/2 âˆ¼4 d
- AEs: Hepatotoxicity, â†“ LVEF, pancytopenia, GI tox, neuropathy, â†“ K
- DDI: [[CYP3A4]] substrate
